Fmr Llc

13F Holdings History for Royalty Pharma plc - Common Stock (RPRX)

Symbol: RPRX on Nasdaq
Investment type: Equity / Common Stock
Latest Disclosed Ownership: 27.9M shares
Security Ownership: 6.5%

Shares, Excluding Options vs Price

Value, Excluding Options

FMR LLC ownership in Royalty Pharma plc Common Stock (RPRX)

2025-11-05 - FMR LLC has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 27.9M shares of Royalty Pharma plc Common Stock (RPRX). This represents 6.5% percent ownership of the company. In their previous filing dated 2025-05-12, FMR LLC had reported owning 39.2M shares, indicating a decrease of -28.9% percent.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
FMR LLC	6.5%	-28.9%	$984M	27.9M	-11,344,879	-28.9%	$35.28	13G/A	9/30/2025	5 Nov 2025 11:44:46
FMR LLC	9.1%	+53.3%	$1.25B	39.2M	+12,936,266	+49.2%	$31.95	13G/A	3/31/2025	12 May 2025 10:39:51
FMR LLC	5.9%		$841M	26.3M			$31.95	13G/A	12/31/2024	12 Feb 2025 09:30:58

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
9/30/2025	0.05%	-0.02%	$987M	28M	-12,371,107	-30.7%	$35.28	Q3 2025
6/30/2025	0.08%	+0%	$1.45B	40.4M	+953,728	+2.42%	$36.03	Q2 2025
3/31/2025	0.08%	+0.03%	$1.23B	39.4M	+13,024,760		$31.13	Q1 2025
12/31/2024	0.04%	0%	$673M	26.4M	-1,510,810	-5.42%	$25.51	Q4 2024
9/30/2024	0.05%	+0%	$789M	27.9M	+3,442	+0.01%	$28.29	Q3 2024
6/30/2024	0.05%	-0.01%	$735M	27.9M	-5,747,515	-17.1%	$26.37	Q2 2024
3/31/2024	0.07%	+0%	$1.02B	33.6M	+2,050,287	+6.49%	$30.37	Q1 2024
12/31/2023	0.07%	+0%	$887M	31.6M	+1,156,757	+3.8%	$28.09	Q4 2023
9/30/2023	0.07%	-0.01%	$826M	30.4M	-3,457,078	-10.2%	$27.14	Q3 2023
6/30/2023	0.09%	-0.02%	$1.04B	33.9M	-6,099,866	-15.3%	$30.74	Q2 2023
3/31/2023	0.13%	-0.01%	$1.44B	40M	-4,126,249	-9.35%	$36.03	Q1 2023
12/31/2022	0.17%	+0%	$1.74B	44.1M	+1,152,495	+2.68%	$39.52	Q4 2022
9/30/2022	0.18%	+0.03%	$1.73B	43M	+7,004,526	+19.5%	$40.18	Q3 2022
6/30/2022	0.15%	+0.03%	$1.51B	36M	+7,748,189	+27.5%	$42.04	Q2 2022
3/31/2022	0.09%	+0.02%	$1.1B	28.2M	+6,125,370	+27.7%	$38.96	Q1 2022
12/31/2021	0.06%	+0.01%	$880M	22.1M	+2,970,034	+15.5%	$39.85	Q4 2021
9/30/2021	0.05%	-0.02%	$691M	19.1M	-4,986,177	-20.7%	$36.14	Q3 2021
6/30/2021	0.08%	-0.01%	$988M	24.1M	-3,856,890	-13.8%	$40.99	Q2 2021
3/31/2021	0.1%	+0.01%	$1.22B	28M	+3,010,273	+12.1%	$43.62	Q1 2021
12/31/2020	0.11%	+0.03%	$1.25B	24.9M	+6,754,241	+37.1%	$50.05	Q4 2020
9/30/2020	0.08%	+0.01%	$754M	18.2M	+1,831,813	+11.2%	$41.45	Q3 2020
6/30/2020	0.08%	+0.08%	$743M	16.4M	+16,356,491	NEW	$45.45	Q2 2020

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.